GT Biopharma, Inc. (GTBP) Tops Q3 EPS by 3c
GT Biopharma, Inc. (NASDAQ: GTBP) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.
GT Biopharma, Inc. (NASDAQ: GTBP) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.